Document is current
Any future updates will be listed below
-
Authors
Raschka, Tamara
To, Jackrite
Hähnel, Tom
Sapienza, Stefano
Ibrahim, Alzhraa
Glaab, Enrico
Gaßner, Heiko
Steidl, Ralph
Winkler, Jürgen
Corvol, Jean-Christophe
Klucken, Jochen
Fröhlich, Holger
-
Funding
Funding for this research was provided by:
Fraunhofer-Institut für Algorithmen und Wissenschaftliches Rechnen SCAI
- License Information
-
More Information
Article History
Received: 3 June 2024
Accepted: 25 June 2025
First Online: 15 July 2025
Declarations
:
: Ralph Steidl is the CEO of Portabiles HCT. Jochen Klucken holds shares of Portabiles HCT. Jean-Christophe Corvol has served in advisory boards for Alzprotect, Bayer, Biogen, Denali, Ferrer, Idorsia, iRegene, Prevail Therapeutic, Servier, Theranexus, UCB; and received grants from Sanofi and the Michael J Fox Foundation outside of this work. Holger Fröhlich has received grants from UCB and AbbVie outside this work. Tamara Raschka, Jackrite To, Tom Hähnel, Stefano Sapienza, Alzhraa Ibrahim, Enrico Glaab, Heiko Gaßner, and Jürgen Winkler declare no competing interests.
